A new report warns that we could very well be at the cusp of a return to a more typical pattern where increases in health-care prices outpace the broader inflation rate.

CVS's already costly deal looks even more expensive after its warning on Thursday of a possible profit decline this year, despite an expected $1.2 billion benefit from tax cuts. CVS shares fell though it reported positive quarterly results.

Just 30 percent of respondents say theyre currently satisfied with their work/life balance, and thats a drop from 45 percent who said so three years ago.

For care providers and other companies all along the pharmaceutical supply chain, this year's flu season has led to higher revenue from increasing hospital visits and drug sales.